Literature DB >> 22982998

Transcriptional profiling of apoptosis: cell death classification moves toward the systems era.

Zhi Yao1, György Szabadkai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982998      PMCID: PMC3495811          DOI: 10.4161/cc.22116

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
In a recent issue of Cell Cycle, Galluzi et al. describe comparative gene expression profiles of the cellular response to three different stressors, with the striking conclusion that cisplatin (CDDP)-induced apoptosis does not rely on direct effects either on mitochondrial integrity or nuclear transcriptional reprogramming due to DNA damage. While their approach gives important insight into the wide range of possibilities a cell can use to cope with stress at the transcriptional level, the paper also highlights the challenges to define cellular death pathways at the systems level. Classifying cell death modalities dates back to the times when the most powerful approach was thorough morphological observation by light and electron microscopy in the ’70s, allowing us to limit the catalog of cell death to merely three types. In the following decades, with the introduction of biochemical approaches and of the series of novel stressor substances tested, the picture became always fuzzier and more complex. The latest effort to categorize the regulated death pathways listed 13 modalities, defined by the combination of at least 30 unique biochemical processes and their sensitivity to numerous pharmacological and genetic modifiers. Recognizing the complexity of the systems involved, modeling based on the fairly well-characterized principal protein components of cell death pathways (considering apoptotic, regulated necrotic and autophagy pathways) and posttranslational biochemical modifications gained importance. Finally, further realizing that the cell death pathways depicted by classical biochemical studies might just scratch the surface, in recent years a series of studies applied large-scale, unbiased gene expression and proteomic approaches to identify novel players in cell fate determination. These studies were particularly boosted by the need to identify novel targets in the pharmacological treatment of drug-resistant cancer. While many cellular stress pathways impinge on gene expression (e.g., unfolded protein response and endoplasmic reticulum stress), modulation of transcription is envisaged to be the most relevant in defining the cellular response to genotoxic stress, which directly targets the integrity of DNA. Indeed, a recent meta-analysis of a large set of gene expression profiles underlying the cellular response to ionizing radiation-induced double-strand breaks confirmed the central role of the transcriptional targets of p53, mediating DNA repair and survival, senescence or programmed cell death. In contrast, the study by Galluzzi et al., using CDDP, which rather causes intra- and interstrand links as the primary mechanism of DNA damage, showed that the enriched transcriptionally modified pathways belong to classes not directly associated with cell death induction, particularly when compared with C2-ceramide and CdCl2, classic inducers of mitochondrial apoptosis. The finding was corroborated by the limited modulation of CDDP-induced reduction of clonogenicity in genetically modified yeast clones, lacking several components of the apoptotic pathway. The study accompanies a previous effort by the same group, where, using genome-wide shRNA profiling, they identified a set of genes that are able to inhibit or enhance the toxicity caused by CDDP (CDDP response modifiers, CRMs). While it would have been expected that the primary target of the CDDP-induced transcriptional stress response will include this gene set, strikingly, only about 10% of the CRM genes were found significantly up or downregulated at the transcriptional level in the present study. This led to the cautious conclusion of the authors that it is likely that regulation at the translational and posttranslational levels is the essential factor in triggering the actual cell death execution machinery following CDDP treatment. Accordingly, the transcriptional regulation accompanying CDDP toxicity is either negligible or responsible for only secondary adaptive stress responses. Indeed, recent studies suggested that DNA damage can cause massive changes in global translational profiles, and the direct interaction of CDDP with a wide range of other cellular components could give rise to extensive posttranslational modification. Notably, the work illustrates the power of combining bioinformatic and experimental approaches to identify new transcriptional targets in the DNA damage response network, but also indicates the formidable challenges when aiming to define and classify cell death pathways based on unbiased genome-wide systems analyses. It will certainly take a lot of effort to get there, but now it also appears achievable if the combined approaches of high-content imaging, transcriptomic and proteomic techniques will be adopted by a larger community of cell stress-focused research groups.
  8 in total

Review 1.  Is cisplatin-induced cell death always produced by apoptosis?

Authors:  V M Gonzalez; M A Fuertes; C Alonso; J M Perez
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

Review 2.  Systems biology analysis of programmed cell death.

Authors:  Shani Bialik; Einat Zalckvar; Yaara Ber; Assaf D Rubinstein; Adi Kimchi
Journal:  Trends Biochem Sci       Date:  2010-05-28       Impact factor: 13.807

Review 3.  Transcriptional modulation induced by ionizing radiation: p53 remains a central player.

Authors:  Sharon Rashi-Elkeles; Ran Elkon; Seagull Shavit; Yaniv Lerenthal; Chaim Linhart; Ana Kupershtein; Ninette Amariglio; Gideon Rechavi; Ron Shamir; Yosef Shiloh
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

Review 4.  Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012.

Authors:  L Galluzzi; I Vitale; J M Abrams; E S Alnemri; E H Baehrecke; M V Blagosklonny; T M Dawson; V L Dawson; W S El-Deiry; S Fulda; E Gottlieb; D R Green; M O Hengartner; O Kepp; R A Knight; S Kumar; S A Lipton; X Lu; F Madeo; W Malorni; P Mehlen; G Nuñez; M E Peter; M Piacentini; D C Rubinsztein; Y Shi; H-U Simon; P Vandenabeele; E White; J Yuan; B Zhivotovsky; G Melino; G Kroemer
Journal:  Cell Death Differ       Date:  2011-07-15       Impact factor: 15.828

Review 5.  Translational regulation of gene expression during conditions of cell stress.

Authors:  Keith A Spriggs; Martin Bushell; Anne E Willis
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

6.  In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival.

Authors:  E Bicaku; Y Xiong; D C Marchion; H S Chon; X B Stickles; N Chen; P L Judson; A Hakam; J Gonzalez-Bosquet; R M Wenham; S M Apte; W Fulp; C L Cubitt; D-T Chen; J M Lancaster
Journal:  Br J Cancer       Date:  2012-05-17       Impact factor: 7.640

7.  Independent transcriptional reprogramming and apoptosis induction by cisplatin.

Authors:  Lorenzo Galluzzi; Ilio Vitale; Laura Senovilla; Tobias Eisenberg; Didac Carmona-Gutierrez; Erika Vacchelli; Thomas Robert; Hugues Ripoche; Nora Jägemann; Caroline Paccard; Nicolas Servant; Philippe Hupé; Vladimir Lazar; Philippe Dessen; Emmanuel Barillot; Hans Zischka; Frank Madeo; Guido Kroemer
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

8.  Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy.

Authors:  P Wynne; C Newton; J A Ledermann; A Olaitan; T A Mould; J A Hartley
Journal:  Br J Cancer       Date:  2007-09-11       Impact factor: 7.640

  8 in total
  2 in total

1.  Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer.

Authors:  Judith Michels; Ilio Vitale; Laura Senovilla; David P Enot; Pauline Garcia; Delphine Lissa; Ken A Olaussen; Catherine Brenner; Jean-Charles Soria; Maria Castedo; Guido Kroemer
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

2.  Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.

Authors:  Lorenzo Galluzzi; Sabrina Marsili; Ilio Vitale; Laura Senovilla; Judith Michels; Pauline Garcia; Erika Vacchelli; Etienne Chatelut; Maria Castedo; Guido Kroemer
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.